A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas

NCT01112384 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Sarcoma

Interventions

DRUG: SB939

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]